SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-16-023662
Filing Date
2016-08-09
Accepted
2016-08-09 16:05:42
Documents
3
Period of Report
2016-08-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 Q2 2016 EARNINGS 8-K tbra-8k_20160809.htm 8-K 23835
2 EX-99.1 tbra-ex991_6.htm EX-99.1 214531
3 GRAPHIC gvoerkdc1zev000001.jpg GRAPHIC 4044
  Complete submission text file 0001564590-16-023662.txt   245445
Mailing Address 701 GATEWAY BLVD SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 701 GATEWAY BLVD SUITE 300 SOUTH SAN FRANCISCO CA 94080 650-741-6625
Tobira Therapeutics, Inc. (Filer) CIK: 0001311596 (see all company filings)

IRS No.: 030422069 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35953 | Film No.: 161817880
SIC: 2834 Pharmaceutical Preparations